Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.4 | 2.25 |
NAV | ₹13.90 | ₹12.35 |
Fund Started | 16 Aug 2022 | 16 Aug 2023 |
Fund Size | ₹519.54 Cr | ₹854.34 Cr |
Exit Load | Exit load of 1%, if redeemed within 30 days. | Exit load of 1%, if redeemed within 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -3.64% | 7.39% |
3 Year | - | - |
5 Year | - | - |
1 Year
3 Year
5 Year
Equity | 94.38% | 95.97% |
Cash | 5.62% | 3.96% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.67% |
Larsen & Toubro Ltd. | 5.81% |
Prestige Estates Projects Ltd. | 5.09% |
ICICI Bank Ltd. | 4.91% |
Can Fin Homes Ltd. | 4.51% |
Ambuja Cements Ltd. | 4.31% |
Ultratech Cement Ltd. | 4.19% |
DLF Ltd. | 4.09% |
Voltas Ltd. | 3.79% |
Blue Star Ltd. | 3.53% |
Name | Assets |
---|---|
Info Edge (India) Ltd. | 4.92% |
Eternal Ltd. | 4.21% |
Suzlon Energy Ltd. | 3.54% |
Affle 3I Ltd. | 3.49% |
Ami Organics Ltd. | 3.47% |
Awfis Space Solutions Ltd. | 3.32% |
The Federal Bank Ltd. | 3.26% |
GE Vernova T&D India Ltd. | 3.05% |
PB Fintech Ltd. | 3.04% |
Krishna Institute of Medical Sciences Ltd | 2.87% |
Name | Arvindkumar Kumaresan Chetty | Hardick Bora |
Start Date | 01 Dec 2022 | 25 Jan 2023 |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity related instruments of entities engaged in and/or expected to benefit from the growth in housing theme. | The Scheme seeks to achieve long term capital appreciation by investing predominantly in equity and equity related securities of Innovative Companies. |
Launch Date | 16 Aug 2022 | 16 Aug 2023 |
Description
Launch Date